Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimia Farma Tbk (KAEF) vs Reksa Dana Syariah Indeks Simas ETF JII (XSSI) Price & Performance

Kimia Farma TbkTrade
Reksa Dana Syariah Indeks Simas ETF JIITrade

Price performance (Past 24H)

Key statistics

Kimia Farma Tbk vs Reksa Dana Syariah Indeks Simas ETF JII — how do they compare? Kimia Farma Tbk trades at Rp454 (market cap 2.53T, 524K 24h volume), while Reksa Dana Syariah Indeks Simas ETF JII trades at Rp62 (market cap 9.93B, 584.6K 24h volume). The key difference: Kimia Farma Tbk is far larger — about 254.8× Reksa Dana Syariah Indeks Simas ETF JII's market cap, and Reksa Dana Syariah Indeks Simas ETF JII is more actively traded (584.6K versus 524K). Which is the better fit depends on your goals.

KAEFXSSI
Market Cap
2.53T9.93B
Volume
524K584.6K
Lot
5.24K5.85K
Turnover
236.25M36.92M
Average Price
450.8763.15
Value
236.25M36.92M
Indicative Equilibrium Price
45462
Indicative Equilibrium Volume
17

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KAEF
View details

About Kimia Farma Tbk

PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.

Read more on KAEF

About Reksa Dana Syariah Indeks Simas ETF JII

Read more on XSSI